Literature DB >> 24002346

Prognosis of ankle syndesmosis injury.

Amy D Sman1, Claire E Hiller, Katherine Rae, James Linklater, Deborah A Black, Kathryn M Refshauge.   

Abstract

PURPOSE: Ankle syndesmosis injury has been associated with persistent pain and prolonged recovery; however, no predictors of prolonged recovery have been identified. The aims of this study were to establish prognosis for ankle syndesmosis injury compared with a lateral ankle sprain and to explore factors associated with prolonged recovery.
METHODS: Participants (n = 63) age 21 ± 3.2 yr, with acute ankle ligament injuries (diagnosed through magnetic resonance imaging), were recruited from 10 sport clubs and sports medicine and physiotherapy clinics in two Australian cities. Follow-up was until full recovery and with preinjury activity level. Time to return to play was compared between injury types using Kaplan-Meier survival curves. Secondary analysis investigated putative factors that increased risk of prolonged recovery. For this analysis, participants unrecovered at 2 wk completed the following: Fear Avoidance Beliefs Questionnaire (FABQ); Star Excursion Balance Test, weight-bearing lunge, and vertical jump (VJ). These variables were correlated with time to recovery using bivariate Pearson's r correlation coefficient.
RESULTS: The median recovery time for conservatively treated ankle syndesmosis injury was 62 and 15 d for lateral sprain. The sport-specific subscale scores of the FABQ were significantly higher (P = 0.017) for the ankle syndesmosis group, whereas vertical jump height was lower for this group, (P = 0.052). No baseline variables were strong predictors (r ≥ 0.6) of recovery. Moderate correlations were found for VJ (r = -0.471, P = 0.004) and the sport-specific subscale of the FABQ (r = 0.463, P = 0.004).
CONCLUSIONS: Conservatively treated ankle syndesmosis injuries took four times longer to recover than lateral ankle sprain. Tests such as VJ and FABQ may identify individuals at risk of prolonged recovery and allow health professionals to determine realistic and appropriate time to recovery.

Entities:  

Mesh:

Year:  2014        PMID: 24002346     DOI: 10.1249/MSS.0000000000000151

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

1.  Magnetic resonance imaging characterization of individual ankle syndesmosis structures in asymptomatic and surgically treated cohorts.

Authors:  Thomas O Clanton; Charles P Ho; Brady T Williams; Rachel K Surowiec; Coley C Gatlin; C Thomas Haytmanek; Robert F LaPrade
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-11-15       Impact factor: 4.342

Review 2.  Management of acute injuries of the tibiofibular syndesmosis.

Authors:  Nicholas M Fort; Amiethab A Aiyer; Jonathan R Kaplan; Niall A Smyth; Anish R Kadakia
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-04-08

3.  Leg Power As an Indicator of Risk of Injury or Illness in Police Recruits.

Authors:  Robin Orr; Rodney Pope; Samantha Peterson; Benjamin Hinton; Michael Stierli
Journal:  Int J Environ Res Public Health       Date:  2016-02-19       Impact factor: 3.390

4.  Effectiveness of a single platelet-rich plasma injection to promote recovery in rugby players with ankle syndesmosis injury.

Authors:  David J Samra; Amy D Sman; Katherine Rae; James Linklater; Kathryn M Refshauge; Claire E Hiller
Journal:  BMJ Open Sport Exerc Med       Date:  2015-09-10

5.  Ankle syndesmosis repair and rehabilitation in professional rugby league players: a case series report.

Authors:  Alex James Latham; Peter Charles Goodwin; Ben Stirling; Adam Budgen
Journal:  BMJ Open Sport Exerc Med       Date:  2017-04-01

6.  Hybrid Fixation Restores Tibiofibular Kinematics for Early Weightbearing After Syndesmotic Injury.

Authors:  Neel K Patel; Calvin Chan; Conor I Murphy; Richard E Debski; Volker Musahl; MaCalus V Hogan
Journal:  Orthop J Sports Med       Date:  2020-09-09

7.  Evidence-Based Surgical Treatment Algorithm for Unstable Syndesmotic Injuries.

Authors:  Markus Regauer; Gordon Mackay; Owen Nelson; Wolfgang Böcker; Christian Ehrnthaller
Journal:  J Clin Med       Date:  2022-01-10       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.